MCL coexpression mm9:973: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 16:11, 17 September 2013
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr18:34784216..34784245,- | p1@Brd8 |
Mm9::chr1:15795720..15795756,+ | p1@Terf1 |
Mm9::chr1:180267871..180267892,- | p3@Hnrnpu |
Mm9::chr3:95021663..95021687,- | p3@Gabpb2 |
Mm9::chr4:32702403..32702443,+ | p1@Casp8ap2 |
Mm9::chr5:144670842..144670916,+ | p1@Pms2 |
Mm9::chr8:108160409..108160489,+ | p1@Ctcf |
Mm9::chr9:15162136..15162203,- | p1@5830418K08Rik |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006259 | DNA metabolic process | 0.00669822721368301 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.00770354454023687 |
GO:0045449 | regulation of transcription | 0.00770354454023687 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.00770354454023687 |
GO:0006350 | transcription | 0.00770354454023687 |
GO:0010468 | regulation of gene expression | 0.00770354454023687 |
GO:0031323 | regulation of cellular metabolic process | 0.00800692130460139 |
GO:0019222 | regulation of metabolic process | 0.00833682578190896 |
GO:0005634 | nucleus | 0.01069598650413 |
GO:0043283 | biopolymer metabolic process | 0.0107983267282468 |
GO:0032389 | MutLalpha complex | 0.0107983267282468 |
GO:0022402 | cell cycle process | 0.0107983267282468 |
GO:0010467 | gene expression | 0.0107983267282468 |
GO:0006260 | DNA replication | 0.0107983267282468 |
GO:0043028 | caspase regulator activity | 0.0107983267282468 |
GO:0010216 | maintenance of DNA methylation | 0.0107983267282468 |
GO:0042162 | telomeric DNA binding | 0.0107983267282468 |
GO:0008656 | caspase activator activity | 0.0107983267282468 |
GO:0007004 | telomere maintenance via telomerase | 0.0129558623042775 |
GO:0032300 | mismatch repair complex | 0.0129558623042775 |
GO:0007049 | cell cycle | 0.0138056554840343 |
GO:0042802 | identical protein binding | 0.0138056554840343 |
GO:0006278 | RNA-dependent DNA replication | 0.014765556762504 |
GO:0008625 | induction of apoptosis via death domain receptors | 0.014765556762504 |
GO:0016505 | apoptotic protease activator activity | 0.014765556762504 |
GO:0050794 | regulation of cellular process | 0.014765556762504 |
GO:0006355 | regulation of transcription, DNA-dependent | 0.014765556762504 |
GO:0006349 | genetic imprinting | 0.014765556762504 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 0.014765556762504 |
GO:0006351 | transcription, DNA-dependent | 0.014765556762504 |
GO:0032774 | RNA biosynthetic process | 0.014765556762504 |
GO:0003677 | DNA binding | 0.0149914116052312 |
GO:0002566 | somatic diversification of immune receptors via somatic mutation | 0.0151983381739104 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 0.0151983381739104 |
GO:0000279 | M phase | 0.0151983381739104 |
GO:0043170 | macromolecule metabolic process | 0.0151983381739104 |
GO:0030983 | mismatched DNA binding | 0.015329864948429 |
GO:0007549 | dosage compensation | 0.015329864948429 |
GO:0050789 | regulation of biological process | 0.0165727056289125 |
GO:0006298 | mismatch repair | 0.0176438701986368 |
GO:0022403 | cell cycle phase | 0.0176438701986368 |
GO:0044424 | intracellular part | 0.0176438701986368 |
GO:0016504 | protease activator activity | 0.0176438701986368 |
GO:0045005 | maintenance of fidelity during DNA-dependent DNA replication | 0.0176438701986368 |
GO:0016070 | RNA metabolic process | 0.020206969527929 |
GO:0005622 | intracellular | 0.020206969527929 |
GO:0006305 | DNA alkylation | 0.020206969527929 |
GO:0006306 | DNA methylation | 0.020206969527929 |
GO:0065007 | biological regulation | 0.0206084635137446 |
GO:0032200 | telomere organization and biogenesis | 0.0215470177903846 |
GO:0000723 | telomere maintenance | 0.0215470177903846 |
GO:0000781 | chromosome, telomeric region | 0.0219499579438009 |
GO:0006304 | DNA modification | 0.0219499579438009 |
GO:0044238 | primary metabolic process | 0.0220368393534729 |
GO:0008624 | induction of apoptosis by extracellular signals | 0.0220368393534729 |
GO:0044237 | cellular metabolic process | 0.0220368393534729 |
GO:0006919 | caspase activation | 0.0220368393534729 |
GO:0043231 | intracellular membrane-bound organelle | 0.0220368393534729 |
GO:0043227 | membrane-bound organelle | 0.0220368393534729 |
GO:0003690 | double-stranded DNA binding | 0.0222388548665342 |
GO:0043280 | positive regulation of caspase activity | 0.0222388548665342 |
GO:0051276 | chromosome organization and biogenesis | 0.0228546865612764 |
GO:0051345 | positive regulation of hydrolase activity | 0.0245968543146773 |
GO:0016445 | somatic diversification of immunoglobulins | 0.030235839008093 |
GO:0003676 | nucleic acid binding | 0.0302919443924271 |
GO:0043281 | regulation of caspase activity | 0.0302919443924271 |
GO:0002200 | somatic diversification of immune receptors | 0.0307973407813843 |
GO:0002377 | immunoglobulin production | 0.0364478222951602 |
GO:0002440 | production of molecular mediator of immune response | 0.0364478222951602 |
GO:0043229 | intracellular organelle | 0.0364478222951602 |
GO:0043226 | organelle | 0.0364478222951602 |
GO:0043414 | biopolymer methylation | 0.037552721260962 |
GO:0040029 | regulation of gene expression, epigenetic | 0.0379139366498252 |
GO:0032259 | methylation | 0.0391283390029987 |
GO:0006261 | DNA-dependent DNA replication | 0.0394580715189841 |
GO:0043566 | structure-specific DNA binding | 0.0406185367480307 |
GO:0008632 | apoptotic program | 0.0409195318913317 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
hemopoietic organ | 4.00e-12 | 29 |
immune organ | 4.00e-12 | 29 |
anterior region of body | 4.64e-10 | 43 |
thymus | 5.72e-09 | 23 |
neck | 5.72e-09 | 23 |
respiratory system epithelium | 5.72e-09 | 23 |
hemolymphoid system gland | 5.72e-09 | 23 |
pharyngeal epithelium | 5.72e-09 | 23 |
thymic region | 5.72e-09 | 23 |
pharyngeal gland | 5.72e-09 | 23 |
entire pharyngeal arch endoderm | 5.72e-09 | 23 |
thymus primordium | 5.72e-09 | 23 |
early pharyngeal endoderm | 5.72e-09 | 23 |
mixed endoderm/mesoderm-derived structure | 5.80e-09 | 35 |
primordium | 7.74e-09 | 134 |
gland of gut | 2.53e-08 | 24 |
pharynx | 4.27e-08 | 24 |
upper respiratory tract | 4.27e-08 | 24 |
chordate pharynx | 4.27e-08 | 24 |
pharyngeal arch system | 4.27e-08 | 24 |
pharyngeal region of foregut | 4.27e-08 | 24 |
hematopoietic system | 4.54e-08 | 45 |
blood island | 4.54e-08 | 45 |
craniocervical region | 4.62e-08 | 36 |
respiratory tract | 1.72e-07 | 41 |
hemolymphoid system | 2.21e-07 | 48 |
immune system | 2.21e-07 | 48 |
respiratory system | 4.09e-07 | 42 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.848341 |
MA0004.1 | 0.434673 |
MA0006.1 | 1.37063 |
MA0007.1 | 1.07722 |
MA0009.1 | 0.870101 |
MA0014.1 | 0.829081 |
MA0017.1 | 0.296816 |
MA0019.1 | 0.688051 |
MA0024.1 | 3.20576 |
MA0025.1 | 1.10341 |
MA0027.1 | 2.51754 |
MA0028.1 | 2.15675 |
MA0029.1 | 0.804619 |
MA0030.1 | 0.811181 |
MA0031.1 | 0.775627 |
MA0038.1 | 0.577528 |
MA0040.1 | 0.882616 |
MA0041.1 | 0.360875 |
MA0042.1 | 0.348174 |
MA0043.1 | 0.966833 |
MA0046.1 | 0.906029 |
MA0048.1 | 0.335404 |
MA0050.1 | 0.472794 |
MA0051.1 | 0.586414 |
MA0052.1 | 0.890676 |
MA0055.1 | 1.64072 |
MA0056.1 | 0 |
MA0057.1 | 0.31126 |
MA0058.1 | 0.341628 |
MA0059.1 | 0.353484 |
MA0060.1 | 4.97066 |
MA0061.1 | 0.224905 |
MA0063.1 | 0 |
MA0066.1 | 3.48842 |
MA0067.1 | 1.21448 |
MA0068.1 | 0.0965831 |
MA0069.1 | 0.891016 |
MA0070.1 | 0.881319 |
MA0071.1 | 0.471969 |
MA0072.1 | 0.872842 |
MA0073.1 | 0.00296875 |
MA0074.1 | 0.531046 |
MA0076.1 | 0.845594 |
MA0077.1 | 0.851175 |
MA0078.1 | 0.61926 |
MA0081.1 | 0.375851 |
MA0083.1 | 0.96604 |
MA0084.1 | 1.54225 |
MA0087.1 | 0.922929 |
MA0088.1 | 1.79592 |
MA0089.1 | 0 |
MA0090.1 | 0.401197 |
MA0091.1 | 0.447561 |
MA0092.1 | 0.401504 |
MA0093.1 | 0.787675 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.519598 |
MA0101.1 | 0.362124 |
MA0103.1 | 0.307078 |
MA0105.1 | 0.41549 |
MA0106.1 | 0.626997 |
MA0107.1 | 0.301222 |
MA0108.2 | 0.710846 |
MA0109.1 | 0 |
MA0111.1 | 0.415012 |
MA0113.1 | 0.598933 |
MA0114.1 | 0.222763 |
MA0115.1 | 0.969632 |
MA0116.1 | 0.27152 |
MA0117.1 | 0.937363 |
MA0119.1 | 0.362692 |
MA0122.1 | 0.957212 |
MA0124.1 | 1.16127 |
MA0125.1 | 1.0872 |
MA0130.1 | 0 |
MA0131.1 | 0.683521 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.00325 |
MA0136.1 | 0.550755 |
MA0139.1 | 0.506952 |
MA0140.1 | 0.519484 |
MA0141.1 | 0.325895 |
MA0142.1 | 0.761136 |
MA0143.1 | 0.615203 |
MA0144.1 | 0.225588 |
MA0145.1 | 0.527241 |
MA0146.1 | 0.385068 |
MA0147.1 | 1.24068 |
MA0148.1 | 0.450593 |
MA0149.1 | 0.367458 |
MA0062.2 | 1.96779 |
MA0035.2 | 0.524137 |
MA0039.2 | 2.04793 |
MA0138.2 | 0.675599 |
MA0002.2 | 0.513194 |
MA0137.2 | 0.32312 |
MA0104.2 | 1.64215 |
MA0047.2 | 0.576767 |
MA0112.2 | 0.527225 |
MA0065.2 | 0.247168 |
MA0150.1 | 0.419883 |
MA0151.1 | 0 |
MA0152.1 | 0.576873 |
MA0153.1 | 1.01988 |
MA0154.1 | 0.100744 |
MA0155.1 | 0.0804339 |
MA0156.1 | 0.314185 |
MA0157.1 | 0.729116 |
MA0158.1 | 0 |
MA0159.1 | 0.246253 |
MA0160.1 | 1.14982 |
MA0161.1 | 0 |
MA0162.1 | 0.71453 |
MA0163.1 | 0.0186439 |
MA0164.1 | 0.551114 |
MA0080.2 | 0.302064 |
MA0018.2 | 0.560731 |
MA0099.2 | 0.669311 |
MA0079.2 | 0.118858 |
MA0102.2 | 1.59466 |
MA0258.1 | 1.13923 |
MA0259.1 | 2.63282 |
MA0442.1 | 0 |